OncoMatch/Clinical Trials/NCT07671846
Patient Anxiety During Magnetic Resonance Imaging
Is NCT07671846 recruiting? Yes, currently enrolling (Jul 2026).
This study is a cross-sectional validation project that aims to translate the MRI-Anxiety Questionnaire (MRI-AQ) into Italian and adapt it culturally for cancer patients undergoing whole-body MRI. The protocol will recruit 175 adult patients at the European Institute of Oncology, use a forward-backward translation process, and evaluate the Italian version with the MRI-AQ itself plus the MRI Fear Survey Schedule (MRI-FSS). The main statistical goal is to show that the Italian version is not inferior to the original in terms of internal consistency. The ultimate purpose is to provide a specific, validated tool for measuring MRI-related anxiety in Italian oncology patients.
Check if I qualifyExtracted eligibility criteria
Cancer type
Tumor Agnostic
Prior therapy
Cannot have received: cancer-related medical treatments or other treatments that could have altered patients' cognition
Previous cancer-related medical treatments or other treatments that could have altered patients' cognition
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07671846 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior cancer-related medical treatments or other treatments that could have altered patients' cognition disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify